Morgan Stanley’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.9M	Sell	204,460 -947,671	-82%	-$8.8M	﹤0.01%	4732
2025 Q1	$15M	Buy	1,152,131 +749,213	+186%	+$9.76M	﹤0.01%	2974
2024 Q4	$7.02M	Buy	402,918 +400,918	+20,046%	+$6.98M	﹤0.01%	3699
2024 Q3	$50.9K	Buy	+2,000	New	+$50.9K	﹤0.01%	6218